SMARTREND NEWS & MARKET ANALYSIS
SmarTrend analyzes over 5,000 stocks simultaneously on an intraday basis using its pattern recognition technology to give you real-time alerts for stocks on the move -- so you can maximize your trading results. Let our system increase your market awareness.
Technical Analysis
ISTA Pharmaceuticals Down 23% Since SmarTrend's Sell Recommendation - 10/31/2009 8:09:10 AM

SmarTrend, our proprietary pattern recognition system, called a Downtrend for ISTA Pharmaceuticals (NASDAQ:ISTA) on September 21, 2009 at $4.75.

Since then, ISTA Pharmaceuticals has returned 23% as of Friday's recent price of $3.66. Want to profit from these alerts?

Go to www.mysmartrend.com now for a FREE two-week trial.


SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html



 



Comtex News Network, Inc. is not a registered investment advisor and does not provide investment advice.
Copyright Comtex News Network, Inc